by Chris Hitchcock | May 9, 2010 | Activism, Birth Control, Pharmaceutical
Today’s the day, ironically enough on Mother’s day, that marks half a century since the FDA approved the pill for contraceptive use in the USA. And, for better or for worse, it’s become part of the fabric of our culture, and allowed women to have...
by Chris Hitchcock | Apr 25, 2010 | Birth Control, Books, magazines, Media, Newspapers, Pharmaceutical
This week was a big one for media coverage of the 50th anniversary of the Pill. And it looks like this is also being taken as an opportunity to reflect on women’s history over the past 50 years, which will also be a good thing. Women often lose our history, and...
by Elizabeth Kissling | Apr 22, 2010 | Birth Control, Disposable menstrual products, Menstruation, New Research, Pharmaceutical
So here’s an odd little study: when women are given a choice between oral contraceptives and the contraceptive vaginal ring, what characteristic is most highly correlated with a slightly greater interest in using the vaginal ring? If you said “tampon...
by Chris Hitchcock | Apr 20, 2010 | Birth Control, Health Care, Menstruation, Ovulation, Pharmaceutical, Reproduction, Sex
It’s starting. With the approaching 50th anniversary of the birth control pill, there will be a flood of anniversary celebrations and reviews of birth control methods. Which is good. We should have those discussions more often. Just say “no” (on the...
by Elizabeth Kissling | Apr 3, 2010 | Birth Control, Menstruation, New Research, Pharmaceutical
We’ve mentioned Yaz and its sister drug Yasmin before, and our friend Holly Grigg-Spall tracks the progress of complaints against them and other oral contraceptives. Yaz and Yasmin were Bayer’s top-selling drugs in 2008, bringing in about $1.8 billion, a 17...